Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05195840 · ClinicalTrials.gov registry record · NA
Personalized Treatment for Eating Disorders Versus CBT-E Trial
A NA study of Eating Disorders, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05195840: Completed NA study of Eating Disorders, sponsored by University of Louisville.
NCT05195840 is a NA study of Eating Disorders that has completed, run by University of Louisville. The registered enrollment target is 80 participants, below the 320-participant average among 37 other Eating Disorders trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05195840, a NA study of Eating Disorders, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The scientific premise, developed from past work, is that treatment personalized based on idiographic models (termed Network Informed Personalized Treatment; NA-PT) will outperform the current gold-standard treatment (Enhanced Cognitive Behavioral Therapy: CBT-E). The study goals are to (1) develop and test the acceptability, feasibility, and preliminary efficacy of a randomization of NA-PT versus CBT-E and (2) to test if network-identified precision targets are the mechanism of change. These goals will ultimately lead to the very first personalized treatment for ED and can be extended to additional psychiatric illnesses. Specific aims are (1) To collect preliminary data on the feasibility and acceptability of the randomization of NA-PT (n=40) for EDs versus CBT-E (n=40), (2) To test the initial clinical efficacy of NA-PT versus CBT-E on clinical outcomes (e.g., ED symptoms, body mass index, quality of life) and (3) To examine if changes in NA-identified, precision targets, as well as in dynamic network structure, are associated with change in clinical outcomes.
Primary Outcome
The Clinical Impairment Assessment (CIA), a self report measure, is assessed at multiple time points throughout the duration of the study and is used to examine the severity of psychosocial impairment caused by eating disorders. The scores range from 0 to 64 with higher scores indicating more impairment.
Conditions Studied
Interventions
- BEHAVIORAL Personalized Treatment for Eating Disorders
- BEHAVIORAL Cognitive Behavioral Therapy for Eating Disorders
Study Locations (1)
Kentucky
- Eating Anxiety Treatment Laboratory and Clinic - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-04-06 |
| Est. Completion | 2026-01-29 |
| Phase | NA |
What the finished NCT05195840 record still lists
NCT05195840 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 320-participant average among 37 other Eating Disorders trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Eating Disorders appearing as the primary indexed condition, and to 2 interventions - of which Personalized Treatment for Eating Disorders is the first listed.
NCT05195840 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05195840 about?
NCT05195840 is a clinical study titled "Personalized Treatment for Eating Disorders Versus CBT-E Trial". The scientific premise, developed from past work, is that treatment personalized based on idiographic models (termed Network Informed Personalized Treatment; NA-PT) will outperform the current gold-standard treatment (Enhanced Cognitive Behavioral Therapy: CBT-E). The study goals are to (1) develop ...
What is the current status of trial NCT05195840?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2022-04-06. Estimated completion is 2026-01-29.
What conditions does trial NCT05195840 study?
This clinical trial studies the following conditions: Eating Disorders.
What interventions are being tested in trial NCT05195840?
The interventions under investigation include: Personalized Treatment for Eating Disorders (BEHAVIORAL), Cognitive Behavioral Therapy for Eating Disorders (BEHAVIORAL).
Who is sponsoring clinical trial NCT05195840?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05195840 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eating Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05195840's enrollment target sits among peer trials
80 17th of 37 higher than 21 of 37 other Eating Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eating Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Targeting Transdiagnostic Self-regulatory Factors and Eating Disorder Pathology Among Adults With BInge-spectrum Eating disOrders: A mHEALTH Interoceptive Exposure Intervention (the Bio-HEALTH Study)
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Diabetes Body Project 2
RECRUITING · NA
-
Acceptability and Feasibility of a Single-Session Online Parent-Focused Intervention Targeting Child Body Image Development
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI